Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $12.6 Million - $14.3 Million
-218,355 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $12.5 Million - $13.9 Million
218,355 New
218,355 $13.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ninety One Uk LTD Portfolio

Follow Ninety One Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.